Arrowhead Pharmaceuticals stock could build on its rally in the third quarter, Morgan Stanley says.

Now, it’s worth noting Stock Advisor’s total average return is 986 % — a market-crushing outperformance compared to 199% for ...

Insiders who bought Edesa Biotech, Inc. ( NASDAQ:EDSA ) stock in the last 12 months were richly rewarded last week.

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

Legend Biotech (NASDAQ: LEGN) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...

(NASDAQ:KYMR) is among the best biotech stocks. TheFly reported on April 13 that KYMR announced that the U.S. Food and Drug ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

We'll know more about the company's medium-term prospects by the end of the year.

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...